Latest & greatest articles for benazepril

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on benazepril or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on benazepril and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for benazepril

1. Retraction: Ahimastos AA, Dart AM, Kingwell BA. Angiotensin II blockade in Marfan's syndrome. N Engl J Med 2008;359:1732. (PubMed)

Retraction: Ahimastos AA, Dart AM, Kingwell BA. Angiotensin II blockade in Marfan's syndrome. N Engl J Med 2008;359:1732. Retraction: Ahimastos AA, Dart AM, Kingwell BA. Angiotensin II blockade in Marfan's syndrome. N Engl J Med 2008;359:1732. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections (...) E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26630147 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Dec 3;373(23):2280. doi: 10.1056/NEJMe1514259. Retraction: Ahimastos AA, Dart AM, Kingwell BA. Angiotensin II blockade in Marfan's syndrome. N Engl J Med 2008;359:1732. [No authors

2015 NEJM

2. Literature search and evidence assessment to examine the effects of minimum volume regulations according to the G-BA directive on outpatient treatment in hospitals

Literature search and evidence assessment to examine the effects of minimum volume regulations according to the G-BA directive on outpatient treatment in hospitals Executive Summary 1 Translation of the executive summary of the rapid report “Literaturrecherche und Evidenzprüfung zur Überprüfung der Auswirkungen der Regelungen über Mindestmengen gemäß der Richtlinie des G-BA über die ambulante Behandlung im Krankenhaus” [Version 1.0; Status: 29.05.2012]). Please note: This translation (...) is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports - Commission No. V11-01 Literature search and evidence assessment to examine the effects of minimum volume regulations according to the G-BA directive on outpatient treatment in hospitals 1 Executive summary of rapid report V11-01 Version 1.0 Evidence on effects of minimum volume regulation pursuant to § 116b SGB V 29.05.2012 Institute

2012 Institute for Quality and Efficiency in Healthcare (IQWiG)

3. Traitement des thromboses veineuses profondes proximales des membres inferieurs par les heparines de bas poids moleculaire: une revue systematique [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic revi

Traitement des thromboses veineuses profondes proximales des membres inferieurs par les heparines de bas poids moleculaire: une revue systematique [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic revi Traitement des thromboses veineuses profondes proximales des membres inferieurs par les heparines de bas poids moleculaire: une revue systematique [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin (...) : a systematic review] Traitement des thromboses veineuses profondes proximales des membres inferieurs par les heparines de bas poids moleculaire: une revue systematique [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review] Lamy O, Cornuz J, Yersin B Authors' objectives To determine the efficacy and safety of subcutaneous low molecular weight heparins (LMWHs) in the initial treatment of proximal deep vein thrombosis (DVT). Searching MEDLINE

1999 DARE.

4. Utilite clinique du Doppler ombilical: resultats des essais controles en population a haut risque et a bas risque [Umbilical Doppler velocimetry: results of controlled trials in high risk and low risk populations]

Utilite clinique du Doppler ombilical: resultats des essais controles en population a haut risque et a bas risque [Umbilical Doppler velocimetry: results of controlled trials in high risk and low risk populations] Utilite clinique du Doppler ombilical: resultats des essais controles en population a haut risque et a bas risque [Umbilical Doppler velocimetry: results of controlled trials in high risk and low risk populations] Utilite clinique du Doppler ombilical: resultats des essais controles (...) en population a haut risque et a bas risque [Umbilical Doppler velocimetry: results of controlled trials in high risk and low risk populations] Goffinet F, Paris J, Nisand I, Breart G Authors' objectives To evaluate the effect of the routine use of umbilical Doppler velocimetry in high- and low-risk pregnancies. The information in the review regarding low-risk pregnancies has not been discussed in this abstract as the data have also been published in an English language journal (see Other

1997 DARE.